Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Cash from Investing Activities (2016 - 2025)

Sunshine Biopharma's Cash from Investing Activities history spans 9 years, with the latest figure at -$50209.0 for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 48.65% year-over-year to -$50209.0; the TTM value through Dec 2025 reached -$836306.0, up 57.75%, while the annual FY2025 figure was -$836306.0, 57.75% up from the prior year.
  • Cash from Investing Activities reached -$50209.0 in Q4 2025 per SBFM's latest filing, up from -$118295.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $18859.0 in Q3 2023 to a low of -$14.6 million in Q4 2022.
  • Average Cash from Investing Activities over 4 years is -$1.4 million, with a median of -$259476.0 recorded in 2023.
  • Peak YoY movement for Cash from Investing Activities: surged 98.16% in 2023, then tumbled 3655.86% in 2024.
  • A 4-year view of Cash from Investing Activities shows it stood at -$14.6 million in 2022, then soared by 98.16% to -$269230.0 in 2023, then soared by 63.69% to -$97770.0 in 2024, then skyrocketed by 48.65% to -$50209.0 in 2025.
  • Per Business Quant, the three most recent readings for SBFM's Cash from Investing Activities are -$50209.0 (Q4 2025), -$118295.0 (Q3 2025), and -$491778.0 (Q2 2025).